Cargando…

Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug

Despite many epilepsy patients respond to antiepileptic drugs (AED) successfully, more than 30% of patients continue to have seizures on multiple AEDs. The refractory epilepsy increases the risk of cognitive deterioration, psychosocial dysfunction, and sudden unexpected death of epilepsy patients (S...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Sang Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Epilepsy Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066627/
https://www.ncbi.nlm.nih.gov/pubmed/24977123
_version_ 1782322191642132480
author Lee, Sang Kun
author_facet Lee, Sang Kun
author_sort Lee, Sang Kun
collection PubMed
description Despite many epilepsy patients respond to antiepileptic drugs (AED) successfully, more than 30% of patients continue to have seizures on multiple AEDs. The refractory epilepsy increases the risk of cognitive deterioration, psychosocial dysfunction, and sudden unexpected death of epilepsy patients (SUDEP). It is important to identify refractory epilepsy early and make the goal of epilepsy treatment as the prevention of decline in social, vocational, and cognitive performances and minimizing the risk of accident or SUDEP. The syndrome of medial temporal lobe epilepsy with hippocampal sclerosis (MTLE with HS) is often resistant to AEDs, and surgically remediable. Initially well-controlled seizures often become intractable to AEDs. There are progressive behavioral changes including increasing memory deficit. Surgical outcome is also worse with longer duration of epilepsy or increasing age at surgery, which suggests that MTLE is a progressive disorder. Some emphasized the ultimate intractability of MTLE in which intractability of MTLE could be evident only after some years following initial diagnosis. However, when patients considered to have intractable epilepsy were followed up for a long period of time, many of them experienced seizure-free state. Some studies clearly demonstrated the wax and wane courses of treatment response in epilepsy. Late remission could be achieved up to in a half of patients. Thus intractable state is not a static condition but a fluctuating one and initial refractoriness does not necessarily mean the final intractability. Even though the chance of seizure remission with AEDs is not high for MTLE, some of them do well respond to drugs. It is even possible to withdraw AEDs for a few patients. Though epilepsy surgery is very effective method to treat MTLE, considering the fluctuation courses of intractability and the possibility of delayed remission, at least two adequate AEDs could be applied to the patients before surgery. However, medical intractability becomes evident by definition, it is not reasonable to delay epilepsy surgery.
format Online
Article
Text
id pubmed-4066627
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Epilepsy Society
record_format MEDLINE/PubMed
spelling pubmed-40666272014-06-30 Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug Lee, Sang Kun J Epilepsy Res Review Despite many epilepsy patients respond to antiepileptic drugs (AED) successfully, more than 30% of patients continue to have seizures on multiple AEDs. The refractory epilepsy increases the risk of cognitive deterioration, psychosocial dysfunction, and sudden unexpected death of epilepsy patients (SUDEP). It is important to identify refractory epilepsy early and make the goal of epilepsy treatment as the prevention of decline in social, vocational, and cognitive performances and minimizing the risk of accident or SUDEP. The syndrome of medial temporal lobe epilepsy with hippocampal sclerosis (MTLE with HS) is often resistant to AEDs, and surgically remediable. Initially well-controlled seizures often become intractable to AEDs. There are progressive behavioral changes including increasing memory deficit. Surgical outcome is also worse with longer duration of epilepsy or increasing age at surgery, which suggests that MTLE is a progressive disorder. Some emphasized the ultimate intractability of MTLE in which intractability of MTLE could be evident only after some years following initial diagnosis. However, when patients considered to have intractable epilepsy were followed up for a long period of time, many of them experienced seizure-free state. Some studies clearly demonstrated the wax and wane courses of treatment response in epilepsy. Late remission could be achieved up to in a half of patients. Thus intractable state is not a static condition but a fluctuating one and initial refractoriness does not necessarily mean the final intractability. Even though the chance of seizure remission with AEDs is not high for MTLE, some of them do well respond to drugs. It is even possible to withdraw AEDs for a few patients. Though epilepsy surgery is very effective method to treat MTLE, considering the fluctuation courses of intractability and the possibility of delayed remission, at least two adequate AEDs could be applied to the patients before surgery. However, medical intractability becomes evident by definition, it is not reasonable to delay epilepsy surgery. Korean Epilepsy Society 2014-06-30 /pmc/articles/PMC4066627/ /pubmed/24977123 Text en Copyright©2014 Korean Epilepsy Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Lee, Sang Kun
Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug
title Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug
title_full Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug
title_fullStr Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug
title_full_unstemmed Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug
title_short Treatment Strategy for the Patient with Hippocampal Sclerosis Who Failed to the First Antiepileptic Drug
title_sort treatment strategy for the patient with hippocampal sclerosis who failed to the first antiepileptic drug
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066627/
https://www.ncbi.nlm.nih.gov/pubmed/24977123
work_keys_str_mv AT leesangkun treatmentstrategyforthepatientwithhippocampalsclerosiswhofailedtothefirstantiepilepticdrug